First Tracks Biotherapeutics, Inc. — Form 10-Q
Filed August 12, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
First Tracks Biotherapeutics entered into a sublease with AnaptysBio, Inc. for approximately 45,057 rentable square feet at 10770 Wateridge Circle, San Diego, CA. The sublease term runs from the later of April 21, 2026 or master landlord consent through April 4, 2028, with an early termination option for Tenant on December 31, 2027 with six months' notice. Rent equals AnaptysBio's basic rent and additional rent under the master lease; specific dollar amounts are not disclosed in the sublease document itself.
Why this rating
Sublease is operational necessity, not transformational. ~45K sq ft facility rental is routine for biotech R&D; 2-year term with exit option is standard. Sized ~15% of company assets; material but non-strategic.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.